Denali Therapeutics Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-15.7% -$18M
$-131M
Free Cash Flow↑+70.1% +$4M
$-2M
Investing Cash Flow↓-87.9% -$151M
$21M
Financing Cash Flow
$192M
Capex↓-70.1% -$4M
$2M
Stock-Based Comp↓-4.5% -$1M
$24M
D&A↑+54.7% +$1M
$3M
SBC Allocated Expense↓-4.5% -$1M
$24M